APA (7th ed.) Citation

EG, D., JG, G., N, A., V, G., BM, C., A, D. G., . . . R, R. (2020). Sodium-glucose cotransporter 2 (SGLT-2) inhibitors and microvascular outcomes in patients with type 2 diabetes: Systematic review and meta-analysis. Journal of endocrinological investigation, 43(3), 289. https://doi.org/10.1007/s40618-019-01103-9

Chicago Style (17th ed.) Citation

EG, Dorsey-Treviño, et al. "Sodium-glucose Cotransporter 2 (SGLT-2) Inhibitors and Microvascular Outcomes in Patients with Type 2 Diabetes: Systematic Review and Meta-analysis." Journal of Endocrinological Investigation 43, no. 3 (2020): 289. https://doi.org/10.1007/s40618-019-01103-9.

MLA (9th ed.) Citation

EG, Dorsey-Treviño, et al. "Sodium-glucose Cotransporter 2 (SGLT-2) Inhibitors and Microvascular Outcomes in Patients with Type 2 Diabetes: Systematic Review and Meta-analysis." Journal of Endocrinological Investigation, vol. 43, no. 3, 2020, p. 289, https://doi.org/10.1007/s40618-019-01103-9.